Basel Medical Group Cash Flow Statement Analysis

Operating, investing, and financing activities in millions SGD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Basel Medical Group Ltd (BMGL) - Annual data in millions SGD
BreakdownFY 2025FY 2024FY 2023FY 2022
Period EndingJun 2025Dec 2024Jun 2023Jun 2022
Operating Activities
Net Income-12.09-12.511.781.98
Depreciation & Amortization1.181.180.560.58
Change in Working Capital-3.08-3.250.290.08
Change in Accounts Receivable-7.28-7.280.540.01
Change in Inventory-0.30-0.30-0.020.00
Change in Accounts Payable4.340.00-0.220.06
Change in Other Working Capital0.184.34-0.060.07
Other Operating Activities-1.0710.23-0.230.07
Net Cash from Operating Activities-4.34-4.342.602.79
Investing Activities
Capital Expenditures-11.04-0.05-0.01-0.09
Acquisitions-10.99-10.990.000.00
Purchases of Investments0.000.000.000.00
Net Cash from Investing Activities-11.04-11.04-0.01-0.09
Financing Activities
Debt Repayment-9.35-5.18-2.94-3.09
Common Stock Issued9.759.750.000.00
Other Financing Activities1.5612.340.00-10.86
Net Cash from Financing Activities16.9116.91-2.94-12.92
Summary
Effect of Forex Changes on Cash-0.50-0.500.000.00
Net Change in Cash1.031.03-0.35-10.22
Cash at Beginning of Period1.951.951.5611.78
Cash at End of Period2.982.981.221.56
Free Cash Flow-15.39-4.402.592.70
Supplemental Disclosures
Interest Paid0.200.410.240.32
Income Taxes Paid0.650.180.290.03